Paradigm creates a platform that allow all patients to participate in clinical trials while also enhancing trial efficiency.
Paradigm has raised $78.0M in total funding. The most recent round was Series B. The last funding was announced in December 2025.
Paradigm's investors include General Catalyst, ARCH Venture Partners, Lux Capital, Mubadala Capital, DFJ Growth.
Paradigm is headquartered in New York, United States.
Paradigm creates a platform that allow all patients to participate in clinical trials while also enhancing trial efficiency.
Paradigm is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Paradigm — Funding & Investors." VCBacked, December 4, 2025, https://www.vcbacked.co/company/paradigm. Accessed July 18, 2026.
VCBacked. (2025). Paradigm — Funding & Investors. Retrieved July 18, 2026, from https://www.vcbacked.co/company/paradigm
{{cite web |title=Paradigm — Funding & Investors |url=https://www.vcbacked.co/company/paradigm |website=VCBacked |access-date=July 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated